Morning Briefing
Summaries of health policy coverage from major news organizations
Aetna Raises Earnings Outlook
In other market news, coverage continues of the cost and effectiveness of Sovaldi, a new drug to treat hepatitis C, and the related earnings gained by Gilead Sciences, its manufacturer.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
